News2021-04-09T01:29:53+00:00

News

MediPrint™ Ophthalmics Announces Promising Results From Its Primary Market Research

Plus, Company Receives Patent for Novel Post-Cataract Surgery Lens SAN DIEGO--(BUSINESS WIRE)--Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight, announces enlightening findings from its primary market research with optometrists and ophthalmologists related to contact lens

11.04.2021|

MediPrint featured in Review of Optometry

The Coming Rise of Drug-delivery Contact Lenses This novel new system could mark a significant advancement for eye care. By Melissa Barnett, OD The use of contact lenses as ocular drug delivery systems was first introduced as an idea decades ago. As contact lenses have

08.16.2021|

MediPrint™ Ophthalmics Announces New Corporate Branding and New Website

Plus, Company Spotlights its Successful First-in-human Clinical Study Results at Premier Eye Care and Investor Conferences SAN DIEGO, CA, USA (Business Wire, June 8th, 2021) – Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight,

06.08.2021|

Recent Posts

Categories

Go to Top